Login / Signup

Comparative Effectiveness of Tofacitinib and Adalimumab in Axial Spondyloarthritis: A Real-World Clinical Context Multicenter Study.

Rudra Prosad GoswamiDebanjali SinhaMoumita ChatterjeeDanveer BhaduShyamashis Das
Published in: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases (2024)
Tofacitinib showed comparable effectiveness with adalimumab in patients with AxSpA at the sixth month, despite lesser response in the initial months, with favorable ICER drug .
Keyphrases